CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2021;62(9):1218-1226.   Published online September 15, 2021
DOI: https://doi.org/10.3341/jkos.2021.62.9.1218

Excel Download

Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Journal of the Korean Ophthalmological Society. 2021;62(9):1218-1226   Crossref logo
Link1 Link2 Link3

Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept
BMC Ophthalmology. 2018;18(1):   Crossref logo
Link1 Link2 Link3

Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept
Journal of the Korean Ophthalmological Society. 2022;63(6):526-534   Crossref logo
Link1 Link2 Link3

Short-term Efficacy of Brolucizumab Injection for Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept
Journal of Retina. 2021;6(2):145-149   Crossref logo
Link1 Link2

Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration
Clinical Ophthalmology. 2015;1315   Crossref logo
Link1

Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
Clinical Ophthalmology. 2013;495   Crossref logo
Link1

Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration
Survey of Ophthalmology. 2018;63(5):638-645   Crossref logo
Link1 Link2

Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye
Clinical Ophthalmology. 2014;2129   Crossref logo
Link1

Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
Clinical Ophthalmology. 2017;Volume 11:161-177   Crossref logo
Link1 Link2

Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept
Journal Fran├žais d'Ophtalmologie. 2017;40(10):832-838   Crossref logo
Link1 Link2